NURTECNOW
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

NURTECNOW Trademark

Serial Number: 90683444

NURTECNOW is a trademark filed by BIOHAVEN PHARMACEUTICAL IRELAND DAC on April 30, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BIOHAVEN PHARMACEUTICAL IRELAND DAC (34 trademarks)

6TH FLOOR, SOUTH BANK HOUSE, BARROW
DUBLIN 4 D04TR29 , IE

Entity Type: 99

Trademark Details

Filing Date

April 30, 2021

Registration Date

Not Registered

Published for Opposition

February 15, 2022

Goods & Services

Printed publications in the nature of brochures, pamphlets, and written articles for medical information and patient support in the field of headache and facial pain

Providing a website featuring financial information about medical benefits and reimbursements available for pharmaceuticals in the field of headache and facial pain; providing online information and financial assistance with insurance benefits and coverage for healthcare providers and patients in the field of headache and facial pain; providing information about insurance coverage and reimbursement for prescription drugs in the field of headache and facial pain; financial administration of a patient assistance program for providing pharmaceuticals for headache and facial pain

Business administration of medication reimbursement programs and services in the field of headache and facial pain; Business administration of patient reimbursement programs in the field of headache and facial pain; Business administration of pharmacy reimbursement programs and services in the field of headache and facial pain

Providing educational and medical information for patients and healthcare providers in the field of headache and facial pain; telemedicine support services in the field of headache and facial pain; dispensing of pharmaceuticals in the field of headache and facial pain

Providing an online non-downloadable software in the nature of a portal for patient support and pharmaceutical reimbursement program services featuring information in the field of headache and facial pain; providing an online non-downloadable software in the nature of a portal for pharmaceutical representatives featuring information in the field of headache and facial pain on physician level aggregated prescription and prior authorization data

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Dec 20, 2022 MAB5
ABANDONMENT - AFTER PUBLICATION
Dec 20, 2022 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Dec 19, 2022 EXAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 24, 2022 EXRA
SOU EXTENSION 1 GRANTED
Sep 22, 2022 EX1G
SOU EXTENSION 1 FILED
Sep 22, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 22, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 12, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 9, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 9, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 9, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 9, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 2, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2021 NWOS
NEW APPLICATION ENTERED
May 4, 2021 NWAP